Giuseppe Traversa

Off-label use of medicines in children: can available evidence avoid useless paediatric trials?

Giovanni Tafuri, Francesco Trotta, Hubert G. M. Leufkens et al. · European Journal of Clinical Pharmacology · 2008 · 50 citations · Full text

How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014

Ilaria Marcianò, Ylenia Ingrasciotta, Francesco Giorgianni et al. · BioDrugs · 2016 · 35 citations

Italian Centres, Clinical Epidemiology, Biosimilar Filgrastim Influence +3

Drug use and acute leukemia

Giuseppe Traversa, Francesca Menniti‐Ippolito, Roberto Da et al. · Pharmacoepidemiology and Drug Safety · 1998 · 33 citations

Stevens-Johnson Syndrome Associated with Drugs and Vaccines in Children: A Case-Control Study

Umberto Raucci, Rossella Rossi, Roberto Da et al. · PLoS ONE · 2013 · 33 citations · Full text

The cerivastatin withdrawal crisis: a “post-mortem” analysis

Marina Maggini, Roberto Raschetti, Giuseppe Traversa et al. · Health Policy · 2004 · 26 citations

Cardiovascular Disease, Cerivastatin Withdrawal Crisis, Pharmacotherapy +2